Scientists at The Wistar Institute have identified a new mechanism behind the chemotherapy resistance that makes ovarian cancer so lethal. The study, funded by top cancer research foundations, was published in The Journal for ImmunoTherapy of Cancer in July 2026.
The research focuses on how ovarian cancer cells evade the effects of chemotherapy, particularly platinum-based drugs. The team discovered a specific molecular pathway that allows cancer cells to survive treatment, offering a potential target for new therapies.
Ovarian cancer is often diagnosed at advanced stages, and resistance to chemotherapy is a major challenge. The findings could lead to more effective treatments and improved survival rates for patients.
Further details from the study were not available at the time of verification, but the discovery represents a significant step in understanding ovarian cancer biology.
